Shah, M. J., Noronha, V., Menon, N. S., Kumar, G., Sahu, L., Parida, Y., Dhanvijay, P., Maske, K., Shah, S., Nawale, K. P., Pachpande, M., Janu, A., Chakrabarty, N., Mittal, N., Bal, M., Rane, S. U., Patil, A., Prabash, K. (2026). Ultra-low-dose immunotherapy plus oral metronomic chemotherapy versus paclitaxel-carboplatin in platinum-sensitive recurrent or metastatic head and neck squamous cell carcinoma: A randomized phase III trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba6007